EP 1003516 A1 20000531 - METHODS OF ADMINISTERING CAMPTOTHECIN COMPOUNDS FOR THE TREATMENT OF CANCER WITH REDUCED SIDE EFFECTS
Title (en)
METHODS OF ADMINISTERING CAMPTOTHECIN COMPOUNDS FOR THE TREATMENT OF CANCER WITH REDUCED SIDE EFFECTS
Title (de)
VERFAHREN ZUR VERABREICHUNG VON CAMPTOTHECIN VERBINDUNGEN ZUR KREBSBEHANDLUNG MIT VERRINGERTEN NEBENWIRKUNGEN
Title (fr)
ADMINISTRATION DE COMPOSES CAMPTOTHECINIQUES DE CANCEROTHERAPIE AVEC REDUCTION DE LEURS EFFETS SECONDAIRES
Publication
Application
Priority
- US 9913906 W 19990618
- US 8978198 P 19980618
Abstract (en)
[origin: WO9965493A1] Methods of administering camptothecin compounds such as irinotecan hydrochloride to reduce a diarrhea side effect and methods of treating cancer and AIDs with camptothecin compounds including administering the camptothecin compounds while maintaining the intestinal lumen and the bile at an alkaline pH.
IPC 1-7
IPC 8 full level
C07D 491/22 (2006.01); A61K 9/00 (2006.01); A61K 9/107 (2006.01); A61K 31/4745 (2006.01); A61K 31/565 (2006.01); A61K 31/575 (2006.01); A61K 33/00 (2006.01); A61K 33/10 (2006.01); A61K 47/02 (2006.01); A61K 47/12 (2006.01); A61P 35/00 (2006.01); A61P 35/02 (2006.01); A61P 43/00 (2006.01)
CPC (source: EP)
A61K 9/0019 (2013.01); A61K 9/1075 (2013.01); A61K 31/4745 (2013.01); A61K 31/565 (2013.01); A61K 31/706 (2013.01); A61K 33/00 (2013.01); A61K 33/10 (2013.01); A61K 47/02 (2013.01); A61K 47/12 (2013.01); A61P 35/00 (2017.12); A61P 35/02 (2017.12); A61P 43/00 (2017.12)
Designated contracting state (EPC)
DE FR GB NL
DOCDB simple family (publication)
WO 9965493 A1 19991223; WO 9965493 A9 20000323; AU 5083399 A 20000105; AU 764370 B2 20030814; CA 2300892 A1 19991223; CN 1325305 A 20011205; EP 1003516 A1 20000531; EP 1003516 A4 20060712; IL 134592 A0 20010430; JP 2002518332 A 20020625
DOCDB simple family (application)
US 9913906 W 19990618; AU 5083399 A 19990618; CA 2300892 A 19990618; CN 99801114 A 19990618; EP 99935334 A 19990618; IL 13459299 A 19990618; JP 2000554373 A 19990618